Learn how tumor marker tests can help doctors diagnose cancer and plan the best possible treatment plan for each person.
Cancer.Net Associate Editors explain research presented at the 2019 ASCO Annual Meeting, including new research in colon cancer, gastric cancer, pancreatic cancer, and leukemia.
ASCO Annual Meeting 2019: Immunotherapy for Lung Cancer, Gastrointestinal Cancers and Targeted Therapy for Breast Cancer
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include treatment advances for advanced lung cancer, stomach cancer, gastroesophageal junction cancer, and breast cancer.
Treating Advanced Prostate Cancer and Kidney Cancer: Research from the 2019 Genitourinary Cancers Symposium
The 2019 Genitourinary Cancers Symposium will feature new research on treatments for prostate cancer and kidney cancer.
In this podcast, Cancer.Net Associate Editor Dr. Michael Williams describes lymphoma research advances presented at the American Society of Hematology Annual Meeting.
Some recent FDA approvals have made many people aware of tumor-agnostic treatments. But what does that mean and how could it benefit someone with cancer? ASCO Chief Medical Officer Richard L. Schilsky gives insight into this new way of thinking about cancer treatment.
Kidney cancer is the sixth most common cancer for men and the tenth most common cancer for women. Cancer.Net Associate Editor Brian Rini, MD, shares 4 things people need to know about kidney cancer.
Lung cancer affects tens of thousands of Americans every year. In this blog post, Cancer.Net Associate Editor Dr. Jyoti Patel describes 9 things every person should know about lung cancer.
In this podcast, Dr. Gary Lyman describes biosimilars for cancer treatment and why they are important. He also talks about why ASCO is releasing a statement on them today.